FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation

European Journal of Immunology

Volumn 43, Issue 11, 2013, Pages 2980-2992

  Li, Fu Jun ^a,b   Schreeder, Daniel M ^c   Li, Ran ^a,b   Wu, Jiongru ^a,b   Davis, Randall S ^a,b,c,d  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

B cells; Fc receptor like; Plasma cell differentiation; TLR

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CPG OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN FC RECEPTOR LIKE 3; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; CROSS LINKING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; INHIBITION KINETICS; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MEMORY CELL; PLASMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SURFACE PROPERTY; SYSTEMIC LUPUS ERYTHEMATOSUS;

B CELLS; FC RECEPTOR-LIKE; PLASMA CELL DIFFERENTIATION; TLR;

ANTIBODY FORMATION; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PLASMA CELLS; RECEPTORS, IMMUNOLOGIC; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9;

EID: 84888038743     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243068     Document Type: Article

References (49)

1. Ravetch, J. V. and Lanier, L. L., Immune inhibitory receptors. Science 2000. 290: 84-89.
2. Hatzivassiliou, G., Miller, I., Takizawa, J., Palanisamy, N., Rao, P. H., Iida, S., Tagawa et al., IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity. 2001. 14: 277-289.
3. Davis, R. S., Wang, Y. H., Kubagawa, H. and Cooper, M. D., Identification of a family of Fc receptor homologs with preferential B cell expression. Proc. Natl. Acad. Sci. USA 2001. 98: 9772-9777.
4. Guselnikov, S. V., Ershova, S. A., Mechetina, L. V., Najakshin, A. M., Volkova, O. Y., Alabyev, B. Y. and Taranin, A. V., A family of highly diverse human and mouse genes structurally links leukocyte FcR, gp42 and PECAM-1. Immunogenetics 2002. 54: 87-95.
5. Davis, R. S., Fc receptor-like molecules. Annu. Rev. Immunol. 2007. 25: 525-560.
6. Schreeder, D. M., Cannon, J. P., Wu, J., Li, R., Shakhmatov, M. A. and Davis, R. S., Cutting edge: FcR-like 6 is an MHC class II receptor. J. Immunol. 2010. 185: 23-27.
7. Campbell, J. A., Davis, R. S., Lilly, L. M., Fremont, D. H., French, A. R. and Carayannopoulos, L. N., Cutting edge: FcR-like 5 on innate B cells is targeted by a poxvirus MHC class I-like immunoevasin. J. Immunol. 2010. 185: 28-32.
8. Wilson, T. J., Fuchs, A. and Colonna, M., Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG. J. Immunol. 2012. 188: 4741-4745.
9. Li, F. J., Ding, S., Pan, J., Shakhmatov, M. A., Kashentseva, E., Wu, J., Li, Y. et al., FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia. Blood 2008. 112: 179-187.
10. Schreeder, D. M., Pan, J., Li, F. J., Vivier, E. and Davis, R. S., FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia. Eur. J. Immunol. 2008. 38: 3159-3166.
11. Moir, S., Ho, J., Malaspina, A., Wang, W., DiPoto, A. C., O'Shea, M. A., Roby, G. et al., Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J. Exp. Med. 2008. 205: 1797-1805.
12. Weiss, G. E., Crompton, P. D., Li, S., Walsh, L. A., Moir, S., Traore, B., Kayentao, K. et al., Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J. Immunol. 2009. 183: 2176-2182.
13. Kochi, Y., Yamada, R., Suzuki, A., Harley, J. B., Shirasawa, S., Sawada, T., Bae, S. C. et al., A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat. Genet. 2005. 37: 478-485.
14. Rakhmanov, M., Keller, B., Gutenberger, S., Foerster, C., Hoenig, M., Driessen, G., van der Burg, M. et al., Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc. Natl. Acad. Sci. USA 2009. 106: 13451-13456.
15. Leu, C. M., Davis, R. S., Gartland, L. A., Fine, W. D. and Cooper, M. D., FcRH1: an activation coreceptor on human B cells. Blood 2005. 105: 1121-1126.
16. Ehrhardt, G. R., Davis, R. S., Hsu, J. T., Leu, C. M., Ehrhardt, A. and Cooper, M. D., The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc. Natl. Acad. Sci. USA 2003. 100: 13489-13494.
17. Haga, C. L., Ehrhardt, G. R., Boohaker, R. J., Davis, R. S. and Cooper, M. D., Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment. Proc. Natl. Acad. Sci. USA 2007. 104: 9770-9775.
18. Kochi, Y., Myouzen, K., Yamada, R., Suzuki, A., Kurosaki, T., Nakamura, Y. and Yamamoto, K., FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J. Immunol. 2009. 183: 5502-5510.
19. Jackson, T. A., Haga, C. L., Ehrhardt, G. R., Davis, R. S. and Cooper, M. D., FcR-like 2 inhibition of B cell receptor-mediated activation of B cells. J. Immunol. 2010. 185: 7405-7412.
20. Polson, A. G., Zheng, B., Elkins, K., Chang, W., Du, C., Dowd, P., Yen, L. et al., Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia. Int. Immunol. 2006. 18: 1363-1373.
21. Nagata, S., Ise, T. and Pastan, I., Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells. J. Immunol. 2009. 182: 7518-7526.
22. Swainson, L. A., Mold, J. E., Bajpai, U. D. and McCune, J. M., Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. J. Immunol. 2010. 184: 3639-3647.
23. Xu, M. J., Zhao, R., Cao, H. and Zhao, Z. J., SPAP2, an Ig family receptor containing both ITIMs and ITAMs. Biochem. Biophys. Res. Commun. 2002. 293: 1037-1046.
24. Won, W. J., Foote, J. B., Odom, M. R., Pan, J., Kearney, J. F. and Davis, R. S., Fc receptor homolog 3 is a novel immunoregulatory marker of marginal zone and b1 B cells. J. Immunol. 2006. 177: 6815-6823.
25. Zhu, Z., Li, R., Li, H., Zhou, T. and Davis, R. S., FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling. Proc. Natl. Acad. Sci. USA 2013. 110: E1282-E1290.
26. Gibson, A. W., Li, F. J., Wu, J., Edberg, J. C., Su, K., Cafardi, J., Wiener, H. et al., The FCRL3 -169CT promoter single-nucleotide polymorphism, which is associated with systemic lupus erythematosus in a Japanese population, predicts expression of receptor protein on CD19+B cells. Arthritis Rheum. 2009. 60: 3510-3512.
27. Chistiakov, D. A. and Chistiakov, A. P., Is FCRL3 a new general autoimmunity gene? Hum. Immunol. 2007. 68: 375-383.
28. Bajpai, U. D., Swainson, L. A., Mold, J. E., Graf, J. D., Imboden, J. B. and McCune, J. M., A functional variant in FCRL3 is associated with higher Fc receptor-like 3 expression on T cell subsets and rheumatoid arthritis disease activity. Arthritis Rheum. 2012. 64: 2451-2459.
29. Weller, S., Braun, M. C., Tan, B. K., Rosenwald, A., Cordier, C., Conley, M. E., Plebani, A. et al., Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004. 104: 3647-3654.
30. Sanz, I., Wei, C., Lee, F. E. and Anolik, J., Phenotypic and functional heterogeneity of human memory B cells. Semin. Immunol. 2008. 20: 67-82.
31. Berkowska, M. A., Driessen, G. J., Bikos, V., Grosserichter-Wagener, C., Stamatopoulos, K., Cerutti, A., He, B. et al., Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood 2011. 118: 2150-2158.
32. Wei, C., Anolik, J., Cappione, A., Zheng, B., Pugh-Bernard, A., Brooks, J., Lee, E. H. et al., A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J. Immunol. 2007. 178: 6624-6633.
33. Amano, M., Baumgarth, N., Dick, M. D., Brossay, L., Kronenberg, M., Herzenberg, L. A. and Strober, S., CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta 2-microglobulin-dependent and independent forms. J. Immunol. 1998. 161: 1710-1717.
34. Bernasconi, N. L., Onai, N. and Lanzavecchia, A., A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003. 101: 4500-4504.
35. Gururajan, M., Jacob, J. and Pulendran, B., Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets. PLoS One 2007. 2: e863.
36. Capolunghi, F., Cascioli, S., Giorda, E., Rosado, M. M., Plebani, A., Auriti, C., Seganti, G. et al., CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J. Immunol. 2008. 180: 800-808.
37. Wrammert, J., Koutsonanos, D., Li, G. M., Edupuganti, S., Sui, J., Morrissey, M., McCausland, M. et al., Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 2011. 208: 181-193.
38. Takeshita, F., Gursel, I., Ishii, K. J., Suzuki, K., Gursel, M. and Klinman, D. M., Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9. Semin. Immunol. 2004. 16: 17-22.
39. Rui, L. X., Vinuesa, C. G., Blasioli, J. and Goodnow, C. C., Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat. Immunol. 2003. 4: 594-600.
40. Rui, L., Healy, J. I., Blasioli, J. and Goodnow, C. C., ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiation. J. Immunol. 2006. 177: 5337-5346.
41. Yasuda, T., Kometani, K., Takahashi, N., Imai, Y., Aiba, Y. and Kurosaki, T., ERKs induce expression of the transcriptional repressor Blimp-1 and subsequent plasma cell differentiation. Sci. Signal. 2011. 4: ra25.
42. Chiorazzi, N. and Ferrarini, M., Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood 2011. 117: 1781-1791.
43. Boule, M. W., Broughton, C., Mackay, F., Akira, S., Marshak-Rothstein, A. and Rifkin, I. R., Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 2004. 199: 1631-1640.
44. Sohn, H. W., Krueger, P. D., Davis, R. S. and Pierce, S. K., FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling. Blood 2011. 118: 6332-6341.
45. Ivashkiv, L. B., Cross-regulation of signaling by ITAM-associated receptors. Nat. Immunol. 2009. 10: 340-347.
46. Dement-Brown, J., Newton, C. S., Ise, T., Damdinsuren, B., Nagata, S. and Tolnay, M., Fc receptor-like 5 promotes B cell proliferation and drives the development of cells displaying switched isotypes. J. Leukoc. Biol. 2012. 91: 59-67.
47. Marshak-Rothstein, A., Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 2006. 6: 823-835.
48. Martin, F. and Kearney, J. F., B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol. Rev. 2000. 175: 70-79.
49. Epstein, A. L., Levy, R., Kim, H., Henle, W., Henle, G. and Kaplan, H. S., Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines. Cancer 1978. 42: 2379-2391.